| |
 |
As July morphed into August, First Opinionators explored why "destination hallway" in emergency rooms and hospital wards isn't going away any time soon, examined the phenomenon of rebound Covid after taking Paxlovid, illuminated the rise in synthetic illicit drugs, and more. You can read the week's worth of essays here. If you have an idea for an essay, or want to submit one you've written, please send it to first.opinion@statnews.com. |
| |
| By Stephen Bohan Brandon Bell/Getty Images The emergency department can offer a glimpse into the future of U.S. hospitals. And that future, in a word, is gridlock. Read More |
| By Joan Bregstein Stephanie Nano/AP With more and more people taking the antiviral Paxlovid to treat early Covid-19, the number of rebound Covid cases will likely increase. Read More |
| Sponsor content by STAT Events Biomarkers: The Foundation of Personalized Oncology Register for a virtual event on August 17 to hear researchers, academics, and business leaders discuss what recent innovations in biomarkers mean for the future of cancer treatments. |
| By Jim Crotty Brendan Smialowski/AFP/Getty Images It is tough to predict which illicit substances will become the "next fentanyl." But they will almost certainly include synthetic drugs. Read More |
| By Standish Fleming Adobe Industry advocates must explain how taking excess profits from pharma giants will affect startups, the real engine of pharma innovation. Read More |
| By Ken Frazier Sue Ogrocki/AP Addressing social drivers of health is often left to government programs and policies. Innovative new companies can do it faster and better. Read More |
| By Martha Rebour and Purvi Parikh Dimas Ardian/Getty Images The reappearance of polio in New York state underscores why the U.S. needs to support global efforts to eradicate the disease. Read More |
| By Dana P. Goldman and Edith A. Perez and Carlos del Rio Adobe Incentives can nudge biopharma companies and contract research organizations to increase participant diversity in clinical trials. Read More |
| By Lawrence O. Gostin and Kevin A. Klock and Sam F. Halabi Adobe Creating a global pandemic treaty will help the world prevent and respond to future infectious disease threats. Read More |
| By Victor Wang Adobe Hospitals and health systems are key to using real-world data and real-world evidence to help develop new drugs and devices. Read More |
| By David Blumenthal JOSH EDELSON/AFP via Getty Images With climate change language intact, the budget reconciliation act may be the most important health care bill since the Affordable Care Act. Read More |
| By Ron Peck Adobe Fast science relies on partnerships that combine innovative technologies and clinical trial models bolstered by better regulatory procedures. Read More |
No comments